A Phase 3 Trial Put a Cannabis Extract Head to Head With Opioids. The Primary Endpoint Was Constipation.
Comments Off on A Phase 3 Trial Put a Cannabis Extract Head to Head With Opioids. The Primary Endpoint Was Constipation.
September 13, 2026
A randomized phase 3 trial of cannabis extract vs opioids in 384 adults with chronic low back pain made constipation its primary endpoint, and the extract group was roughly fourfold less likely to develop it. Pain relief favored the extract by 0.34…
Endocannabinoid System & Chronic Low Back Pain: Phase 3 Trial Results on Cannabis Sativa Extracts
Comments Off on Endocannabinoid System & Chronic Low Back Pain: Phase 3 Trial Results on Cannabis Sativa Extracts
May 5, 2026
This phase 3 randomized controlled trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 against placebo over 12 weeks. Results showed a modest but statistically significant pain reduction. The trial provides important…
Clinical Research on Full-Spectrum Cannabis Extract VER-01 for Back Pain
Comments Off on Clinical Research on Full-Spectrum Cannabis Extract VER-01 for Back Pain
April 15, 2026
The full-spectrum cannabis extract VER-01 was evaluated in a phase 3 clinical trial for chronic low back pain. This study demonstrated meaningful pain reduction and safety over 12 weeks and extended follow-up. VER-01 offers promising evidence as a…